| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | ATN1 NACA CITED1 ZMIZ1 SSBP3 TRIM24 KMT2D BRD4 DYRK1B CTBP1 RERE HCFC2 NOTCH1 | 1.93e-08 | 303 | 114 | 13 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | ATN1 NACA CITED1 ZMIZ1 SSBP3 TRIM24 KMT2D ATF7IP TLE3 BRD4 DYRK1B CTBP1 RERE HCFC2 NOTCH1 | 7.32e-07 | 562 | 114 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ALX3 FOXN1 TCF7 CEBPB SOX30 GLIS3 IRX1 LHX6 FOXJ3 TFAP4 ZBTB24 ZNF750 FOXD3 KMT2D HOXD8 ZIC5 SKOR2 ZSCAN5C DLX3 EMX2 SIX2 NOTCH1 EBF4 PROP1 | 1.14e-06 | 1412 | 114 | 24 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ALX3 TCF7 CEBPB SOX30 GLIS3 CHD7 IRX1 KDM6B LHX6 TRIM24 FOXJ3 TFAP4 ZBTB24 ZNF750 FOXD3 HOXD8 ZIC5 SKOR2 ZSCAN5C DLX3 EMX2 SIX2 EBF4 PROP1 | 2.03e-06 | 1459 | 114 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF7 CEBPB SOX30 GLIS3 CHD7 IRX1 KDM6B TRIM24 FOXJ3 TFAP4 ZBTB24 ZNF750 FOXD3 ZIC5 SKOR2 ZSCAN5C DLX3 EMX2 SIX2 NOTCH1 EBF4 PROP1 | 2.59e-06 | 1271 | 114 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXN1 CEBPB SOX30 GLIS3 FOXJ3 TFAP4 ZNF750 KMT2D HOXD8 DLX3 SIX2 NOTCH1 EBF4 PROP1 | 3.78e-06 | 560 | 114 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXN1 CEBPB SOX30 GLIS3 FOXJ3 TFAP4 ZNF750 KMT2D HOXD8 DLX3 SIX2 NOTCH1 EBF4 PROP1 | 4.27e-06 | 566 | 114 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | chromatin binding | CEBPB CITED1 CHD7 KDM6B MBD6 TRIM24 ZNF750 SETDB1 ATXN7 BRD4 SKOR2 CTBP1 DLX3 RERE NOTCH1 PROP1 | 4.62e-06 | 739 | 114 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF7 CEBPB SOX30 GLIS3 CHD7 IRX1 KDM6B TRIM24 FOXJ3 TFAP4 ZBTB24 ZNF750 FOXD3 ZIC5 SKOR2 ZSCAN5C DLX3 EMX2 SIX2 EBF4 PROP1 | 6.69e-06 | 1244 | 114 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 9.25e-05 | 320 | 114 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 SORBS2 ATN1 MAP1A NACA CITED1 ZMIZ1 SSBP3 TRIM24 KMT2D ATF7IP TLE3 BRD4 DYRK1B CTBP1 RERE HCFC2 NOTCH1 | 9.87e-05 | 1160 | 114 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.07e-04 | 326 | 114 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.28e-04 | 120 | 114 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 SORBS2 ATN1 MAP1A NACA CITED1 ZMIZ1 SSBP3 TRIM24 KMT2D ATF7IP TLE3 BRD4 DYRK1B CTBP1 RERE HCFC2 NOTCH1 | 6.60e-04 | 1356 | 114 | 18 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.41e-03 | 10 | 114 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 1.41e-03 | 10 | 114 | 2 | GO:0140537 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXN1 CEBPB SOX30 EGLN1 NACA GLIS3 ID4 CITED1 CHD7 ZMIZ1 KDM6B SSBP3 FOXJ3 CCNK TFAP4 ZNF750 FOXD3 KMT2D TNFSF11 HOXD8 ATXN7 BRD4 MED25 DLX3 SIX2 NOTCH1 EBF4 PROP1 | 1.47e-09 | 1390 | 114 | 28 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TCF7 CEBPB ATN1 SOX30 NACA GLIS3 ID4 CITED1 IRX1 TRIM24 TFAP4 ZBTB24 ZNF750 SETDB1 FOXD3 TNFSF11 HOXD8 ATF7IP TLE3 SKOR2 MED25 CTBP1 RERE HCFC2 NOTCH1 PROP1 | 3.35e-08 | 1399 | 114 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TCF7 CEBPB ATN1 SOX30 NACA GLIS3 ID4 CITED1 IRX1 TRIM24 TFAP4 ZBTB24 ZNF750 SETDB1 FOXD3 TNFSF11 HOXD8 ATF7IP TLE3 SKOR2 MED25 CTBP1 RERE HCFC2 NOTCH1 PROP1 | 4.09e-08 | 1413 | 114 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TCF7 CEBPB ATN1 SOX30 NACA GLIS3 ID4 IRX1 ZBTB24 ZNF750 SETDB1 FOXD3 TNFSF11 HOXD8 ATF7IP SKOR2 MED25 CTBP1 HCFC2 NOTCH1 PROP1 | 2.80e-07 | 1053 | 114 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ALX3 FOXN1 XIRP1 TCF7 CEBPB EGLN1 EFEMP2 NACA ID4 CITED1 CHD7 IRX1 ZMIZ1 COL18A1 TNFSF11 HOXD8 TLE3 ROBO1 DLX3 EMX2 SIX2 NOTCH1 PROP1 | 3.78e-07 | 1269 | 114 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | ALX3 TCF7 CEBPB FN1 CECR2 EGLN1 CITED1 CHD7 IRX1 ZMIZ1 KDM6B SSBP3 CCNK COL18A1 SETDB1 FOXD3 KMT2D HOXD8 ZIC5 BRD4 DLX3 SIX2 NOTCH1 | 3.19e-06 | 1437 | 114 | 23 | GO:0009790 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ALX3 TCF7 CEBPB CECR2 EGLN1 CITED1 CHD7 ZMIZ1 SSBP3 CCNK SETDB1 FOXD3 KMT2D ZIC5 BRD4 SIX2 NOTCH1 | 9.81e-06 | 906 | 114 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ALX3 TCF7 CEBPB CECR2 EGLN1 CITED1 CHD7 ZMIZ1 SSBP3 CCNK SETDB1 FOXD3 KMT2D ZIC5 BRD4 SIX2 NOTCH1 | 1.36e-05 | 929 | 114 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | epithelium development | FOXN1 TCF7 CEBPB CARMIL2 CECR2 SIPA1L3 DACT2 ID4 CITED1 CHD7 IRX1 KDM6B SSBP3 ZNF750 COL18A1 TNFSF11 ZIC5 SAFB2 ROBO1 DLX3 SIX2 NOTCH1 | 1.55e-05 | 1469 | 114 | 22 | GO:0060429 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FOXN1 CARMIL2 CECR2 EGLN1 EFEMP2 ID4 CITED1 CHD7 IRX1 KDM6B ZIC5 ROBO1 DLX3 SIX2 NOTCH1 | 1.64e-05 | 750 | 114 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 5.65e-05 | 38 | 114 | 4 | GO:0061384 | |
| GeneOntologyBiologicalProcess | brain development | CCDC85C ID4 CITED1 CHD7 ZMIZ1 KDM6B SSBP3 LHX6 ZIC5 SKOR2 ROBO1 RERE EMX2 NOTCH1 PROP1 | 7.76e-05 | 859 | 114 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | forebrain development | CCDC85C ID4 CHD7 ZMIZ1 KDM6B LHX6 ZIC5 ROBO1 EMX2 NOTCH1 PROP1 | 8.50e-05 | 489 | 114 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | tube morphogenesis | FOXN1 TCF7 FN1 CECR2 EGLN1 EFEMP2 CITED1 CHD7 IRX1 ZMIZ1 COL18A1 ZIC5 HRG ROBO1 EMX2 SIX2 NOTCH1 | 1.47e-04 | 1125 | 114 | 17 | GO:0035239 |
| GeneOntologyBiologicalProcess | head development | CCDC85C ID4 CITED1 CHD7 ZMIZ1 KDM6B SSBP3 LHX6 ZIC5 SKOR2 ROBO1 RERE EMX2 NOTCH1 PROP1 | 1.63e-04 | 919 | 114 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 1.67e-04 | 93 | 114 | 5 | GO:0034243 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.68e-04 | 210 | 114 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 2.26e-04 | 54 | 114 | 4 | GO:0050922 | |
| GeneOntologyBiologicalProcess | pallium development | 2.36e-04 | 222 | 114 | 7 | GO:0021543 | |
| GeneOntologyBiologicalProcess | tube development | FOXN1 TCF7 FN1 CECR2 EGLN1 EFEMP2 DACT2 CITED1 CHD7 IRX1 ZMIZ1 SSBP3 COL18A1 ZIC5 HRG ROBO1 EMX2 SIX2 NOTCH1 | 2.37e-04 | 1402 | 114 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.63e-04 | 226 | 114 | 7 | GO:0045580 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 2.79e-04 | 57 | 114 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | FOXN1 TCF7 CEBPB CARMIL2 FN1 LAG3 RAET1G ZMIZ1 CD2 TNFSF11 BRD4 HRG PEAR1 | 2.79e-04 | 756 | 114 | 13 | GO:0050865 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 2.94e-04 | 105 | 114 | 5 | GO:0032784 | |
| GeneOntologyBiologicalProcess | regulation of cell development | FOXN1 TCF7 CEBPB CARMIL2 FN1 NACA LAG3 ID4 CHD7 ZMIZ1 RHEX CD2 TNFSF11 BRD4 ROBO1 NOTCH1 | 3.41e-04 | 1095 | 114 | 16 | GO:0060284 |
| GeneOntologyBiologicalProcess | hemopoiesis | DOCK1 FOXN1 TCF7 CEBPB CARMIL2 SIPA1L3 LAG3 DACT2 CHD7 ZMIZ1 SSBP3 ZBTB24 RHEX CD2 TNFSF11 BRD4 NOTCH1 | 3.91e-04 | 1223 | 114 | 17 | GO:0030097 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | TCF7 CEBPB SPATA31A3 ATN1 SPATA31A7 SOX30 ID4 CHD7 FOXJ3 SPATA31A6 SPATA31A5 KMT2D SPATA31A1 TLE3 SAFB2 RNF38 NOTCH1 | 4.38e-04 | 1235 | 114 | 17 | GO:0003006 |
| GeneOntologyBiologicalProcess | in utero embryonic development | CEBPB EGLN1 CITED1 CHD7 ZMIZ1 CCNK SETDB1 FOXD3 KMT2D BRD4 NOTCH1 | 4.67e-04 | 596 | 114 | 11 | GO:0001701 |
| GeneOntologyBiologicalProcess | telencephalon development | 5.20e-04 | 332 | 114 | 8 | GO:0021537 | |
| GeneOntologyCellularComponent | chromatin | ALX3 FOXN1 TCF7 CEBPB BICRA CECR2 SOX30 CHD7 IRX1 ZMIZ1 LHX6 TRIM24 FOXJ3 TFAP4 WDR43 FOXD3 HOXD8 ATXN7 BRD4 DLX3 EMX2 SIX2 EBF4 PROP1 | 1.17e-06 | 1480 | 114 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | TCF7 CEBPB SSBP3 TFAP4 FOXD3 ATXN7 ATF7IP TLE3 SKOR2 MED25 CTBP1 SIX2 PROP1 | 2.24e-05 | 596 | 114 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | acrosomal vesicle | SPATA31A3 SPATA31A7 PRSS55 SPATA31A6 SPATA31A5 SPATA31A1 NOTCH1 | 1.38e-04 | 206 | 114 | 7 | GO:0001669 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CASC3 TCF7 CEBPB BICRA CECR2 KDM6B CCNK INTS5 KMT2D AAAS ATXN7 TLE3 BRD4 MED25 RERE HCFC2 SF3A2 CPSF7 | 4.62e-04 | 1377 | 114 | 18 | GO:0140513 |
| MousePheno | abnormal craniofacial morphology | ALX3 DOCK1 CEBPB CECR2 CHD7 IRX1 ZMIZ1 SSBP3 MBD6 FIGN COL18A1 KMT2D TNFSF11 MAST4 ZIC5 BRD4 SKOR2 ROBO1 RERE EMX2 SIX2 NOTCH1 | 6.13e-05 | 1372 | 92 | 22 | MP:0000428 |
| MousePheno | craniofacial phenotype | ALX3 DOCK1 CEBPB CECR2 CHD7 IRX1 ZMIZ1 SSBP3 MBD6 FIGN COL18A1 KMT2D TNFSF11 MAST4 ZIC5 BRD4 SKOR2 ROBO1 RERE EMX2 SIX2 NOTCH1 | 6.13e-05 | 1372 | 92 | 22 | MP:0005382 |
| MousePheno | dilated third ventricle | 7.00e-05 | 34 | 92 | 4 | MP:0000827 | |
| MousePheno | decreased bone ossification | 9.83e-05 | 37 | 92 | 4 | MP:0020040 | |
| MousePheno | abnormal incus long process morphology | 1.28e-04 | 3 | 92 | 2 | MP:0030396 | |
| MousePheno | abnormal stapes head morphology | 1.28e-04 | 3 | 92 | 2 | MP:0030402 | |
| MousePheno | increased cochlear outer hair cell number | 1.45e-04 | 16 | 92 | 3 | MP:0004401 | |
| MousePheno | abnormal axial skeleton morphology | DOCK1 CHCHD10 CEBPB CHAT CHD7 IRX1 KDM6B SSBP3 FIGN TFAP4 COL18A1 KMT2D TNFSF11 MAST4 HOXD8 ZIC5 ATXN7 BRD4 ROBO1 EMX2 SIX2 NOTCH1 | 1.51e-04 | 1458 | 92 | 22 | MP:0002114 |
| Domain | DUF4599 | 6.06e-07 | 12 | 113 | 4 | PF15371 | |
| Domain | DUF4599 | 6.06e-07 | 12 | 113 | 4 | IPR027970 | |
| Domain | Homeobox_CS | 1.75e-05 | 186 | 113 | 8 | IPR017970 | |
| Domain | Atrophin-like | 3.63e-05 | 2 | 113 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 3.63e-05 | 2 | 113 | 2 | PF03154 | |
| Domain | Homeobox | 8.90e-05 | 234 | 113 | 8 | PF00046 | |
| Domain | HOMEOBOX_1 | 9.45e-05 | 236 | 113 | 8 | PS00027 | |
| Domain | HOX | 9.73e-05 | 237 | 113 | 8 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.03e-04 | 239 | 113 | 8 | PS50071 | |
| Domain | Homeobox_dom | 1.03e-04 | 239 | 113 | 8 | IPR001356 | |
| Domain | AT_hook | 1.14e-04 | 16 | 113 | 3 | PF02178 | |
| Domain | Homeodomain-like | 1.88e-04 | 332 | 113 | 9 | IPR009057 | |
| Domain | - | 3.26e-04 | 283 | 113 | 8 | 1.10.10.60 | |
| Domain | Bromodomain_CS | 5.07e-04 | 26 | 113 | 3 | IPR018359 | |
| Domain | HTH_motif | 8.11e-04 | 69 | 113 | 4 | IPR000047 | |
| Domain | HMGI/Y_DNA-bd_CS | 8.57e-04 | 31 | 113 | 3 | IPR000637 | |
| Domain | FN3 | 1.33e-03 | 199 | 113 | 6 | PS50853 | |
| Domain | BROMODOMAIN_1 | 1.44e-03 | 37 | 113 | 3 | PS00633 | |
| Domain | Bromodomain | 1.56e-03 | 38 | 113 | 3 | PF00439 | |
| Domain | FN3_dom | 1.71e-03 | 209 | 113 | 6 | IPR003961 | |
| Domain | SH3_2 | 1.84e-03 | 86 | 113 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.84e-03 | 86 | 113 | 4 | PF07653 | |
| Domain | Methyl_CpG_DNA-bd | 1.93e-03 | 11 | 113 | 2 | IPR001739 | |
| Domain | MBD | 1.93e-03 | 11 | 113 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 1.93e-03 | 11 | 113 | 2 | IPR016177 | |
| Domain | MBD | 1.93e-03 | 11 | 113 | 2 | SM00391 | |
| Domain | MBD | 1.93e-03 | 11 | 113 | 2 | PS50982 | |
| Domain | BROMODOMAIN_2 | 1.94e-03 | 41 | 113 | 3 | PS50014 | |
| Domain | BROMO | 2.08e-03 | 42 | 113 | 3 | SM00297 | |
| Domain | Bromodomain | 2.08e-03 | 42 | 113 | 3 | IPR001487 | |
| Domain | - | 2.08e-03 | 42 | 113 | 3 | 1.20.920.10 | |
| Domain | TF_fork_head_CS_2 | 2.71e-03 | 46 | 113 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.88e-03 | 47 | 113 | 3 | IPR018122 | |
| Domain | fn3 | 3.05e-03 | 162 | 113 | 5 | PF00041 | |
| Domain | FH | 3.24e-03 | 49 | 113 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 3.24e-03 | 49 | 113 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 3.24e-03 | 49 | 113 | 3 | PS00658 | |
| Domain | Fork_head_dom | 3.24e-03 | 49 | 113 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 3.24e-03 | 49 | 113 | 3 | PS50039 | |
| Domain | Forkhead | 3.24e-03 | 49 | 113 | 3 | PF00250 | |
| Domain | HMG_box | 4.05e-03 | 53 | 113 | 3 | PF00505 | |
| Domain | Post-SET_dom | 4.12e-03 | 16 | 113 | 2 | IPR003616 | |
| Domain | PostSET | 4.12e-03 | 16 | 113 | 2 | SM00508 | |
| Domain | POST_SET | 4.12e-03 | 16 | 113 | 2 | PS50868 | |
| Domain | HMG | 4.27e-03 | 54 | 113 | 3 | SM00398 | |
| Domain | - | 4.50e-03 | 55 | 113 | 3 | 1.10.30.10 | |
| Domain | FN3 | 5.36e-03 | 185 | 113 | 5 | SM00060 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.40e-05 | 59 | 74 | 5 | M46460 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.62e-05 | 10 | 74 | 3 | MM15156 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 4.85e-05 | 14 | 74 | 3 | M27402 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 6.73e-05 | 42 | 74 | 4 | M27272 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 9.66e-05 | 46 | 74 | 4 | M48243 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.31e-04 | 26 | 74 | 3 | MM14793 | |
| Pubmed | TCF7 ATN1 BICRA NACA CCDC85C ID4 CHD7 PATL1 ZMIZ1 SSBP3 MBD6 FIGN LHX6 TRIM24 TFAP4 PRR12 RSBN1 SETDB1 KMT2D ATXN7 ATF7IP TLE3 CTBP1 RERE HCFC2 GARRE1 CPSF7 | 1.63e-13 | 1429 | 116 | 27 | 35140242 | |
| Pubmed | 2.26e-12 | 6 | 116 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.26e-12 | 6 | 116 | 5 | 25930072 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ALX3 FOXN1 TCF7 CEBPB SOX30 ID4 IRX1 LHX6 FOXJ3 TFAP4 ZBTB24 FOXD3 KMT2D HOXD8 SKOR2 DLX3 RERE EMX2 SIX2 EBF4 PROP1 | 2.79e-12 | 908 | 116 | 21 | 19274049 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ALX3 TCF7 CEBPB SOX30 IRX1 LHX6 FOXJ3 TFAP4 FOXD3 HOXD8 ZIC5 SKOR2 DLX3 EMX2 SIX2 PROP1 | 4.25e-11 | 544 | 116 | 16 | 28473536 |
| Pubmed | ATN1 RBM26 CHD7 TRIM24 CCNK PRR12 KMT2D TLE3 BRD4 RERE CPSF7 | 1.78e-09 | 268 | 116 | 11 | 33640491 | |
| Pubmed | 2.35e-09 | 152 | 116 | 9 | 38360978 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | ATN1 BICRA CHD7 ZMIZ1 MBD6 TRIM24 TFAP4 PRR12 KMT2D TLE3 CTBP1 RERE | 2.49e-09 | 351 | 116 | 12 | 38297188 |
| Pubmed | 1.53e-08 | 24 | 116 | 5 | 32212159 | ||
| Pubmed | CCDC85C CHD7 ZMIZ1 TRIM24 PRR12 SETDB1 KMT2D ATF7IP TLE3 BRD4 CTBP1 RERE | 1.73e-08 | 418 | 116 | 12 | 34709266 | |
| Pubmed | CBLL1 CASC3 CEBPB SIPA1L3 NACA RBM26 CHD7 SSBP3 FOXJ3 CCNK WDR43 PRR12 RSBN1 COL18A1 INTS5 ATXN7 MED25 CTBP1 HCFC2 SF3A2 CEP170B | 2.29e-08 | 1497 | 116 | 21 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L SORBS2 ATN1 CHD7 PATL1 CCNK TFAP4 INTS5 KMT2D ATXN7 TLE3 BRD4 SAFB2 RIPOR1 RERE | 4.88e-08 | 774 | 116 | 15 | 15302935 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SHANK1 ATXN2L CASC3 SORBS2 ATN1 FN1 EFEMP2 RBM26 PRR16 SAFB2 KCNN1 CTBP1 NOTCH1 | 5.17e-08 | 560 | 116 | 13 | 21653829 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | BICRA CECR2 CHD7 TRIM24 PRR12 KMT2D ATF7IP TLE3 BRD4 DYRK1B CTBP1 | 1.03e-07 | 398 | 116 | 11 | 35016035 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.06e-07 | 184 | 116 | 8 | 32908313 | |
| Pubmed | 3.70e-07 | 83 | 116 | 6 | 28794006 | ||
| Pubmed | ATXN2L CEBPB BICRA RBM26 CHD7 TRIM24 FOXJ3 CCNK TFAP4 PRR12 KMT2D TLE3 BRD4 SAFB2 SF3A2 CPSF7 | 8.37e-07 | 1103 | 116 | 16 | 34189442 | |
| Pubmed | ATXN2L FAM193B ATN1 EFEMP2 MBD6 CCNK SETDB1 ATXN7 CTBP1 RERE NOTCH1 CPSF7 | 9.65e-07 | 608 | 116 | 12 | 16713569 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 CASC3 BICRA SIPA1L3 CCDC85C PARD3B PATL1 ZMIZ1 SSBP3 FOXJ3 TFAP4 COL18A1 ATXN7 TLE3 RIPOR1 CTBP1 RERE CEP170B | 2.20e-06 | 1489 | 116 | 18 | 28611215 |
| Pubmed | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. | 2.62e-06 | 29 | 116 | 4 | 17928865 | |
| Pubmed | TCF7 RBM26 GLIS3 CITED1 TRIM24 FOXJ3 TFAP4 ZBTB24 ZNF750 ZIC5 TLE3 BRD4 ZSCAN5C | 3.19e-06 | 808 | 116 | 13 | 20412781 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.28e-06 | 457 | 116 | 10 | 32344865 | |
| Pubmed | 4.12e-06 | 469 | 116 | 10 | 27634302 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L CASC3 SORBS2 CARMIL2 SIPA1L3 CCDC85C PARD3B KIAA0753 MAST4 BRD4 DYRK1B GARRE1 CEP170B | 6.32e-06 | 861 | 116 | 13 | 36931259 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 CEBPB CHD7 TFAP4 WDR43 PRR12 INTS5 KMT2D AAAS ZIC5 BRD4 SAFB2 HCFC2 SF3A2 SIX2 CPSF7 | 6.46e-06 | 1294 | 116 | 16 | 30804502 |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 20225273 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 10814707 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22703800 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11726661 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 28475860 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 14670999 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30355436 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 27821476 | ||
| Pubmed | The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis. | 1.10e-05 | 2 | 116 | 2 | 38040752 | |
| Pubmed | MAST4 regulates stem cell maintenance with DLX3 for epithelial development and amelogenesis. | 1.10e-05 | 2 | 116 | 2 | 38945953 | |
| Pubmed | Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IP. | 1.10e-05 | 2 | 116 | 2 | 26813693 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25811130 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32687658 | ||
| Pubmed | KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress. | 1.10e-05 | 2 | 116 | 2 | 36797416 | |
| Pubmed | KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription. | 1.10e-05 | 2 | 116 | 2 | 34001062 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.47e-05 | 430 | 116 | 9 | 35044719 | |
| Pubmed | 1.60e-05 | 15 | 116 | 3 | 26522984 | ||
| Pubmed | 1.73e-05 | 95 | 116 | 5 | 24029230 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 ATXN2L BICRA RBM26 CHD7 TRIM24 CCNK WDR43 RSBN1 ATF7IP BRD4 SAFB2 CPSF7 | 1.87e-05 | 954 | 116 | 13 | 36373674 |
| Pubmed | 1.96e-05 | 16 | 116 | 3 | 19121383 | ||
| Pubmed | 1.96e-05 | 16 | 116 | 3 | 24780627 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B RIN3 CEBPB BICRA SIPA1L3 KDM6B MBD6 PRR12 INTS5 KMT2D BRD4 RIPOR1 CEP170B NOTCH1 | 1.96e-05 | 1105 | 116 | 14 | 35748872 |
| Pubmed | TCF7 EGLN1 ID4 CITED1 FOXJ3 TFAP4 FOXD3 HOXD8 BRD4 EMX2 SIX2 | 2.65e-05 | 709 | 116 | 11 | 22988430 | |
| Pubmed | 2.84e-05 | 18 | 116 | 3 | 17537792 | ||
| Pubmed | 2.84e-05 | 18 | 116 | 3 | 14645126 | ||
| Pubmed | Inflammation-associated miR-155 activates differentiation of muscular satellite cells. | 3.30e-05 | 3 | 116 | 2 | 30273359 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22110129 | ||
| Pubmed | Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. | 3.30e-05 | 3 | 116 | 2 | 23161489 | |
| Pubmed | Role for compartmentalization in nephron progenitor differentiation. | 3.30e-05 | 3 | 116 | 2 | 23487745 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27566587 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28007623 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31562298 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 30452683 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19131340 | ||
| Pubmed | Basal Forebrain Cholinergic Neurons Have Specific Characteristics during the Perinatal Period. | 3.30e-05 | 3 | 116 | 2 | 38755010 | |
| Pubmed | T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. | 3.30e-05 | 3 | 116 | 2 | 22109558 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27749841 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 14536086 | ||
| Pubmed | Discovery of a hidden transient state in all bromodomain families. | 3.30e-05 | 3 | 116 | 2 | 33468647 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24321094 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19103190 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28747631 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17182555 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 36318489 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 30399154 | ||
| Pubmed | Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development. | 3.30e-05 | 3 | 116 | 2 | 30076146 | |
| Pubmed | Sex steroid blockade enhances thymopoiesis by modulating Notch signaling. | 3.30e-05 | 3 | 116 | 2 | 25332287 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ALX3 TCF7 GLIS3 ID4 CITED1 SSBP3 TRIM24 ZBTB24 CTBP1 RERE EMX2 EBF4 | 3.83e-05 | 877 | 116 | 12 | 20211142 |
| Pubmed | 3.95e-05 | 20 | 116 | 3 | 15173589 | ||
| Pubmed | Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium. | 5.32e-05 | 22 | 116 | 3 | 25758227 | |
| Pubmed | Fibroblast growth factor receptor-Frs2α signaling is critical for nephron progenitors. | 5.32e-05 | 22 | 116 | 3 | 25641696 | |
| Pubmed | 5.74e-05 | 396 | 116 | 8 | 26687479 | ||
| Pubmed | 6.05e-05 | 399 | 116 | 8 | 35987950 | ||
| Pubmed | 6.10e-05 | 23 | 116 | 3 | 23117660 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 18824585 | ||
| Pubmed | Effects of Emx2 inactivation on the gene expression profile of neural precursors. | 6.59e-05 | 4 | 116 | 2 | 16420441 | |
| Pubmed | Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea. | 6.59e-05 | 4 | 116 | 2 | 16972005 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 21283129 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 29306897 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 20181723 | ||
| Pubmed | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 6.59e-05 | 4 | 116 | 2 | 28246602 | |
| Pubmed | SUMOylation Potentiates ZIC Protein Activity to Influence Murine Neural Crest Cell Specification. | 6.59e-05 | 4 | 116 | 2 | 34638777 | |
| Pubmed | miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin. | 6.59e-05 | 4 | 116 | 2 | 27693493 | |
| Pubmed | KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. | 6.59e-05 | 4 | 116 | 2 | 36525973 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 23055267 | ||
| Pubmed | The ribosomal chaperone NACA recruits PHD2 to cotranslationally modify HIF-α. | 6.59e-05 | 4 | 116 | 2 | 36219563 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 17150957 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 26163108 | ||
| Pubmed | 6.75e-05 | 205 | 116 | 6 | 20436479 | ||
| Pubmed | 6.94e-05 | 407 | 116 | 8 | 12693553 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 6.95e-05 | 24 | 116 | 3 | 26116661 | |
| Pubmed | 7.51e-05 | 209 | 116 | 6 | 36779422 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 8.97e-05 | 134 | 116 | 5 | 25452129 | |
| Pubmed | 9.37e-05 | 425 | 116 | 8 | 24999758 | ||
| Pubmed | Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. | 9.96e-05 | 137 | 116 | 5 | 30862715 | |
| Interaction | TLE3 interactions | CBLL1 CEBPB ATN1 CECR2 ZMIZ1 FIGN LHX6 PRR12 KMT2D TLE3 BRD4 RERE SIX2 NOTCH1 CPSF7 | 1.81e-09 | 376 | 109 | 15 | int:TLE3 |
| Interaction | CRX interactions | ATN1 BICRA CHD7 ZMIZ1 TRIM24 TFAP4 PRR12 KMT2D MYO15B ATXN7 TLE3 RERE | 1.32e-08 | 254 | 109 | 12 | int:CRX |
| Interaction | NCK2 interactions | DOCK1 SORBS2 ATN1 RBM26 MBD6 PRR16 HOXD8 FYB1 SF3A2 CPSF7 EPHA8 | 1.81e-07 | 262 | 109 | 11 | int:NCK2 |
| Interaction | MED23 interactions | CEBPB FOXJ3 CCNK INTS5 TLE3 BRD4 DYRK1B MED25 CTBP1 NOTCH1 CPSF7 | 2.11e-07 | 266 | 109 | 11 | int:MED23 |
| Interaction | ERG interactions | 3.69e-07 | 223 | 109 | 10 | int:ERG | |
| Interaction | SP7 interactions | ATN1 BICRA CHD7 ZMIZ1 SSBP3 TRIM24 PRR12 KMT2D TLE3 RERE CPSF7 | 7.94e-07 | 304 | 109 | 11 | int:SP7 |
| Interaction | EYA4 interactions | 8.10e-07 | 243 | 109 | 10 | int:EYA4 | |
| Interaction | RBM10 interactions | 1.17e-06 | 253 | 109 | 10 | int:RBM10 | |
| Interaction | TBR1 interactions | 2.69e-06 | 113 | 109 | 7 | int:TBR1 | |
| Interaction | TBXT interactions | 3.20e-06 | 116 | 109 | 7 | int:TBXT | |
| Interaction | EGR2 interactions | 4.18e-06 | 171 | 109 | 8 | int:EGR2 | |
| Interaction | UBP1 interactions | 4.40e-06 | 79 | 109 | 6 | int:UBP1 | |
| Interaction | TLX1 interactions | 4.96e-06 | 175 | 109 | 8 | int:TLX1 | |
| Interaction | SOX7 interactions | 5.47e-06 | 82 | 109 | 6 | int:SOX7 | |
| Interaction | TCF7 interactions | 6.62e-06 | 23 | 109 | 4 | int:TCF7 | |
| Interaction | ALG13 interactions | 6.90e-06 | 183 | 109 | 8 | int:ALG13 | |
| Interaction | HNF1B interactions | 9.08e-06 | 190 | 109 | 8 | int:HNF1B | |
| Interaction | LHX8 interactions | 9.85e-06 | 53 | 109 | 5 | int:LHX8 | |
| Interaction | PHF20 interactions | 9.85e-06 | 53 | 109 | 5 | int:PHF20 | |
| Interaction | DDX17 interactions | CBLL1 ATXN2L RIN3 CEBPB FN1 MBD6 WDR43 TLE3 BRD4 SF3A2 NOTCH1 | 1.98e-05 | 426 | 109 | 11 | int:DDX17 |
| Interaction | TLE5 interactions | FOXN1 ATN1 EFEMP2 CCNK ZBTB24 MYO15B TLE3 MED25 SIX2 PROP1 CPSF7 | 2.84e-05 | 443 | 109 | 11 | int:TLE5 |
| Interaction | HCFC1 interactions | 3.07e-05 | 293 | 109 | 9 | int:HCFC1 | |
| Interaction | YY1 interactions | FOXN1 ATXN2L CHD7 MBD6 TRIM24 ATF7IP BRD4 HCFC2 SF3A2 NOTCH1 CPSF7 | 3.55e-05 | 454 | 109 | 11 | int:YY1 |
| Interaction | BUB3 interactions | 3.83e-05 | 232 | 109 | 8 | int:BUB3 | |
| Interaction | KDM1A interactions | CEBPB CCDC85C CHD7 ZMIZ1 TRIM24 ZBTB24 PRR12 ZNF750 SETDB1 KMT2D ATF7IP TLE3 BRD4 CTBP1 RERE NOTCH1 | 4.54e-05 | 941 | 109 | 16 | int:KDM1A |
| Interaction | SETD1B interactions | 5.39e-05 | 75 | 109 | 5 | int:SETD1B | |
| Interaction | PAX9 interactions | 7.55e-05 | 130 | 109 | 6 | int:PAX9 | |
| Interaction | AR interactions | CEBPB ATN1 FN1 RBM26 CHD7 ZMIZ1 TRIM24 CCNK PRR12 KMT2D AAAS TLE3 BRD4 CTBP1 RERE CPSF7 | 8.46e-05 | 992 | 109 | 16 | int:AR |
| Interaction | QPRT interactions | 9.28e-05 | 84 | 109 | 5 | int:QPRT | |
| Interaction | ZMIZ1 interactions | 9.30e-05 | 44 | 109 | 4 | int:ZMIZ1 | |
| Interaction | CREBBP interactions | CEBPB CITED1 KDM6B TRIM24 SETDB1 KMT2D ATF7IP TLE3 BRD4 DYRK1B MED25 CTBP1 | 9.67e-05 | 599 | 109 | 12 | int:CREBBP |
| Interaction | EFEMP2 interactions | 9.69e-05 | 136 | 109 | 6 | int:EFEMP2 | |
| Interaction | IRF4 interactions | 9.81e-05 | 85 | 109 | 5 | int:IRF4 | |
| Interaction | NUP35 interactions | 1.02e-04 | 424 | 109 | 10 | int:NUP35 | |
| Interaction | CTNNB1 interactions | ATXN2L TCF7 SORBS2 SIPA1L3 CCDC85C PARD3B CITED1 ZMIZ1 KMT2D TLE3 BRD4 CTBP1 NOTCH1 PROP1 CPSF7 EPHA8 | 1.03e-04 | 1009 | 109 | 16 | int:CTNNB1 |
| Interaction | EWSR1 interactions | CASC3 CEBPB ATN1 FN1 BICRA CECR2 NACA SSBP3 ZBTB24 PRR12 ATF7IP BRD4 SAFB2 CTBP1 CPSF7 | 1.08e-04 | 906 | 109 | 15 | int:EWSR1 |
| Interaction | GSC interactions | 1.10e-04 | 87 | 109 | 5 | int:GSC | |
| Interaction | TADA3 interactions | 1.18e-04 | 141 | 109 | 6 | int:TADA3 | |
| Interaction | FEV interactions | 1.19e-04 | 203 | 109 | 7 | int:FEV | |
| Interaction | HNF4A interactions | 1.26e-04 | 275 | 109 | 8 | int:HNF4A | |
| Interaction | SMARCC2 interactions | 1.28e-04 | 353 | 109 | 9 | int:SMARCC2 | |
| Interaction | NFIC interactions | 1.46e-04 | 210 | 109 | 7 | int:NFIC | |
| Interaction | RERE interactions | 1.50e-04 | 93 | 109 | 5 | int:RERE | |
| Interaction | OXER1 interactions | 1.54e-04 | 50 | 109 | 4 | int:OXER1 | |
| Interaction | KAT8 interactions | 1.66e-04 | 95 | 109 | 5 | int:KAT8 | |
| Interaction | RBBP5 interactions | 1.68e-04 | 287 | 109 | 8 | int:RBBP5 | |
| Interaction | EP300 interactions | CASC3 CEBPB NACA RBM26 CITED1 PATL1 TRIM24 RSBN1 KMT2D ATXN7 TLE3 BRD4 DYRK1B SAFB2 CTBP1 RERE SF3A2 NOTCH1 CPSF7 | 1.73e-04 | 1401 | 109 | 19 | int:EP300 |
| Interaction | SOX9 interactions | 1.83e-04 | 97 | 109 | 5 | int:SOX9 | |
| Interaction | TLX3 interactions | 1.85e-04 | 291 | 109 | 8 | int:TLX3 | |
| Interaction | FASN interactions | CBLL1 ATXN2L RIN3 CEBPB FN1 BICRA RBM26 MBD6 TFAP4 WDR43 PRR12 AAAS BRD4 RERE HCFC2 SF3A2 | 1.86e-04 | 1062 | 109 | 16 | int:FASN |
| Interaction | VASP interactions | 1.98e-04 | 294 | 109 | 8 | int:VASP | |
| Interaction | FOXK2 interactions | 2.24e-04 | 225 | 109 | 7 | int:FOXK2 | |
| Interaction | NFIX interactions | 2.36e-04 | 227 | 109 | 7 | int:NFIX | |
| Interaction | ZNF516 interactions | 2.39e-04 | 56 | 109 | 4 | int:ZNF516 | |
| Interaction | KLF3 interactions | 2.43e-04 | 228 | 109 | 7 | int:KLF3 | |
| Interaction | ZNF503 interactions | 2.57e-04 | 57 | 109 | 4 | int:ZNF503 | |
| Interaction | H4C13 interactions | 2.74e-04 | 58 | 109 | 4 | int:H4C13 | |
| Interaction | SSBP4 interactions | 2.93e-04 | 59 | 109 | 4 | int:SSBP4 | |
| Interaction | KMT2A interactions | 3.09e-04 | 314 | 109 | 8 | int:KMT2A | |
| Interaction | EHMT2 interactions | 3.16e-04 | 315 | 109 | 8 | int:EHMT2 | |
| Interaction | POU5F1 interactions | NACA CHD7 TRIM24 COL18A1 SETDB1 FOXD3 ZIC5 BRD4 HRG CTBP1 SF3A2 | 3.25e-04 | 584 | 109 | 11 | int:POU5F1 |
| Interaction | SETD1A interactions | 3.26e-04 | 170 | 109 | 6 | int:SETD1A | |
| Interaction | YWHAQ interactions | CBLL1 ATXN2L RIN3 SORBS2 CEBPB CARMIL2 FN1 SIPA1L3 PARD3B CHAT PANK1 CCNK MAST4 BRD4 GARRE1 CEP170B | 3.31e-04 | 1118 | 109 | 16 | int:YWHAQ |
| Interaction | RUNX3 interactions | 3.33e-04 | 61 | 109 | 4 | int:RUNX3 | |
| Interaction | PAX8 interactions | 3.43e-04 | 111 | 109 | 5 | int:PAX8 | |
| Interaction | SUPT5H interactions | 3.75e-04 | 408 | 109 | 9 | int:SUPT5H | |
| Interaction | TEAD1 interactions | 3.92e-04 | 176 | 109 | 6 | int:TEAD1 | |
| Interaction | PSME3IP1 interactions | 4.20e-04 | 116 | 109 | 5 | int:PSME3IP1 | |
| Interaction | MAD2L1 interactions | 4.44e-04 | 252 | 109 | 7 | int:MAD2L1 | |
| Interaction | VSX1 interactions | 4.51e-04 | 66 | 109 | 4 | int:VSX1 | |
| Interaction | CARMIL2 interactions | 4.57e-04 | 28 | 109 | 3 | int:CARMIL2 | |
| Interaction | RNPS1 interactions | 5.03e-04 | 425 | 109 | 9 | int:RNPS1 | |
| Interaction | H4C4 interactions | 5.08e-04 | 29 | 109 | 3 | int:H4C4 | |
| Interaction | EYA2 interactions | 5.10e-04 | 121 | 109 | 5 | int:EYA2 | |
| Interaction | ETV4 interactions | 5.34e-04 | 69 | 109 | 4 | int:ETV4 | |
| Interaction | CPNE1 interactions | 5.34e-04 | 69 | 109 | 4 | int:CPNE1 | |
| Interaction | VARS1 interactions | 5.34e-04 | 260 | 109 | 7 | int:VARS1 | |
| Interaction | GATA3 interactions | 5.41e-04 | 187 | 109 | 6 | int:GATA3 | |
| Interaction | KRTAP6-2 interactions | 5.41e-04 | 187 | 109 | 6 | int:KRTAP6-2 | |
| Interaction | PAX7 interactions | 5.70e-04 | 124 | 109 | 5 | int:PAX7 | |
| Interaction | QKI interactions | 5.88e-04 | 190 | 109 | 6 | int:QKI | |
| Interaction | SLC45A1 interactions | 5.98e-04 | 7 | 109 | 2 | int:SLC45A1 | |
| Interaction | SMCHD1 interactions | 6.04e-04 | 191 | 109 | 6 | int:SMCHD1 | |
| Interaction | RUNX1T1 interactions | 6.36e-04 | 127 | 109 | 5 | int:RUNX1T1 | |
| Interaction | MAML1 interactions | 6.61e-04 | 73 | 109 | 4 | int:MAML1 | |
| Interaction | KLF5 interactions | 6.74e-04 | 195 | 109 | 6 | int:KLF5 | |
| Interaction | HOXA1 interactions | 7.08e-04 | 356 | 109 | 8 | int:HOXA1 | |
| Interaction | MED15 interactions | 7.32e-04 | 131 | 109 | 5 | int:MED15 | |
| Interaction | SUZ12 interactions | CBLL1 SORBS2 CEBPB CECR2 PARD3B CHD7 SETDB1 KMT2D BRD4 SAFB2 CPSF7 | 7.34e-04 | 644 | 109 | 11 | int:SUZ12 |
| Interaction | TRIP6 interactions | 7.34e-04 | 358 | 109 | 8 | int:TRIP6 | |
| Interaction | GATA2 interactions | 7.49e-04 | 199 | 109 | 6 | int:GATA2 | |
| Interaction | CBX3 interactions | CEBPB FN1 CHD7 KDM6B TRIM24 WDR43 RSBN1 ZNF750 SETDB1 ATF7IP BRD4 | 7.53e-04 | 646 | 109 | 11 | int:CBX3 |
| Interaction | CXXC1 interactions | 7.57e-04 | 132 | 109 | 5 | int:CXXC1 | |
| Interaction | TEAD4 interactions | 7.70e-04 | 76 | 109 | 4 | int:TEAD4 | |
| Interaction | BAIAP2 interactions | 7.89e-04 | 201 | 109 | 6 | int:BAIAP2 | |
| Interaction | MBD1 interactions | 8.09e-04 | 77 | 109 | 4 | int:MBD1 | |
| Interaction | H4C5 interactions | 8.15e-04 | 34 | 109 | 3 | int:H4C5 | |
| Interaction | UBE2I interactions | CEBPB TRIM24 SETDB1 AAAS KCNA5 ATXN7 ATF7IP BRD4 CTBP1 FYB1 PROP1 | 8.32e-04 | 654 | 109 | 11 | int:UBE2I |
| Interaction | PAX6 interactions | 8.47e-04 | 366 | 109 | 8 | int:PAX6 | |
| Interaction | DPY30 interactions | 8.52e-04 | 204 | 109 | 6 | int:DPY30 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.75e-04 | 8 | 116 | 2 | chr9q12 | |
| GeneFamily | Fibronectin type III domain containing | 3.16e-04 | 160 | 67 | 5 | 555 | |
| GeneFamily | Forkhead boxes | 5.40e-04 | 43 | 67 | 3 | 508 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 7.28e-04 | 11 | 67 | 2 | 1025 | |
| GeneFamily | PDZ domain containing | 2.44e-03 | 152 | 67 | 4 | 1220 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 4.04e-07 | 155 | 114 | 8 | M8944 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.23e-05 | 176 | 114 | 7 | M39223 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CASC3 MAP1A PPM1E GLIS3 ID4 CHD7 PATL1 ZMIZ1 FOXJ3 MAST4 FAM222A ROBO1 RERE HCFC2 SIX2 | 1.53e-05 | 946 | 114 | 15 | M39169 |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 1.59e-05 | 122 | 114 | 6 | M10276 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 2.80e-05 | 200 | 114 | 7 | M9923 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN | 2.80e-05 | 200 | 114 | 7 | M9285 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | SHANK1 ALX3 CHCHD10 CECR2 LAG3 GLIS3 CCDC85C ID4 CITED1 CHD7 IRX1 ZMIZ1 FIGN LHX6 PRR16 FNDC1 DLX3 EMX2 FYB1 CEP170B EBF4 | 2.16e-08 | 967 | 110 | 21 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | SHANK1 ALX3 CHCHD10 CECR2 LAG3 GLIS3 CCDC85C ID4 CITED1 CHD7 ZMIZ1 LHX6 PRR16 FNDC1 EMX2 FYB1 SIX2 CEP170B EBF4 | 5.24e-07 | 968 | 110 | 19 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | SHANK1 ALX3 CHCHD10 SORBS2 CECR2 LAG3 GLIS3 CCDC85C CHD7 ZMIZ1 FIGN LHX6 FNDC1 FAM222A DLX3 EMX2 FYB1 CEP170B EBF4 | 5.66e-07 | 973 | 110 | 19 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_100 | 7.23e-07 | 97 | 110 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | ALX3 CHCHD10 CECR2 CCDC85C CITED1 CHD7 IRX1 FIGN LHX6 DLX3 EMX2 FYB1 EBF4 | 1.32e-06 | 483 | 110 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SHANK1 SORBS2 MAP1A CECR2 LAG3 GLIS3 ID4 CHD7 ZMIZ1 FIGN LHX6 PRR16 FNDC1 ZIC5 EMX2 FYB1 CEP170B EBF4 | 2.62e-06 | 976 | 110 | 18 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SHANK1 CHCHD10 SORBS2 CECR2 LAG3 GLIS3 ID4 CHD7 ZMIZ1 LHX6 FNDC1 FAM222A DLX3 EMX2 FYB1 SIX2 CEP170B EBF4 | 2.94e-06 | 984 | 110 | 18 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 3.63e-06 | 175 | 110 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.82e-06 | 248 | 110 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | SHANK1 CECR2 LAG3 IRX1 ZMIZ1 LHX6 FOXD3 FNDC1 ZIC5 FYB1 CEP170B EBF4 | 8.86e-06 | 489 | 110 | 12 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_100 | 1.20e-05 | 98 | 110 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 2.74e-05 | 68 | 110 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.61e-05 | 72 | 110 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | SHANK1 CECR2 LAG3 GLIS3 ID4 IRX1 ZMIZ1 LHX6 PRR16 FOXD3 FNDC1 ZIC5 DLX3 FYB1 CEP170B EBF4 | 3.79e-05 | 967 | 110 | 16 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | SHANK1 ALX3 CECR2 LAG3 GLIS3 ID4 CITED1 CHD7 ZMIZ1 LHX6 PRR16 FNDC1 DLX3 FYB1 CEP170B EBF4 | 4.33e-05 | 978 | 110 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | ALX3 CHCHD10 CECR2 CCDC85C CITED1 CHD7 LHX6 EMX2 FYB1 SIX2 EBF4 | 4.48e-05 | 486 | 110 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 5.40e-05 | 40 | 110 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.00e-04 | 89 | 110 | 5 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.03e-04 | 279 | 110 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.13e-04 | 210 | 110 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 1.31e-04 | 50 | 110 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_100 | 1.43e-04 | 96 | 110 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | SHANK1 ALX3 LAG3 GLIS3 ID4 IRX1 ZMIZ1 LHX6 PRR16 FOXD3 FNDC1 EMX2 FYB1 CEP170B EBF4 | 1.47e-04 | 972 | 110 | 15 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.65e-04 | 99 | 110 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 1.73e-04 | 100 | 110 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 2.26e-04 | 488 | 110 | 10 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200 | 2.86e-04 | 25 | 110 | 3 | gudmap_developingGonad_e14.5_ epididymis_200_k3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 3.02e-04 | 62 | 110 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | BICRA RBM26 CHD7 KDM6B SSBP3 FIGN TRIM24 PANK1 RSBN1 MAST4 TLE3 ROBO1 EMX2 | 3.05e-04 | 815 | 110 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 3.22e-04 | 417 | 110 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.84e-04 | 66 | 110 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | TCF7 CECR2 SIPA1L3 GLIS3 CCDC85C CHD7 ZMIZ1 SSBP3 FIGN PRR12 INTS5 FAM222A DYRK1B MED25 EMX2 SF3A2 | 4.01e-04 | 1187 | 110 | 16 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.47e-04 | 31 | 110 | 3 | gudmap_developingGonad_e14.5_ testes_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | SORBS2 CECR2 GLIS3 CCDC85C CHD7 IRX1 FIGN TFAP4 WDR43 COL18A1 AAAS ZIC5 MED25 SF3A2 | 6.01e-04 | 991 | 110 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.24e-04 | 75 | 110 | 4 | gudmap_developingGonad_e14.5_ ovary_1000_k4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-08 | 187 | 116 | 8 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-08 | 187 | 116 | 8 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-08 | 190 | 116 | 8 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-08 | 191 | 116 | 8 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-08 | 191 | 116 | 8 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-08 | 193 | 116 | 8 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-08 | 193 | 116 | 8 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-07 | 172 | 116 | 7 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-07 | 186 | 116 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-07 | 187 | 116 | 7 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-07 | 187 | 116 | 7 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-07 | 187 | 116 | 7 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.09e-07 | 187 | 116 | 7 | ab6f4d387218b4651fdadbf269806c1ddc96a1d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-07 | 187 | 116 | 7 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.32e-07 | 188 | 116 | 7 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.32e-07 | 188 | 116 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-07 | 189 | 116 | 7 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-07 | 189 | 116 | 7 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-07 | 189 | 116 | 7 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-07 | 189 | 116 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-07 | 190 | 116 | 7 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-07 | 190 | 116 | 7 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-07 | 190 | 116 | 7 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-07 | 192 | 116 | 7 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-07 | 192 | 116 | 7 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 8.64e-07 | 197 | 116 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 8.64e-07 | 197 | 116 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 9.56e-07 | 200 | 116 | 7 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.56e-07 | 200 | 116 | 7 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.56e-07 | 200 | 116 | 7 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 131 | 116 | 6 | 6d08555222c4ebb8cc0d3902e5c03e958d9e0d58 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-06 | 162 | 116 | 6 | 7e6d20704d77b28512690f882f9ddbbd9c5c3228 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-06 | 162 | 116 | 6 | 2c193f766f2cefe67682f34325d1de6aed778f49 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 171 | 116 | 6 | 1176577841bb6cff27ca288e0c89d2e2242efbb3 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 172 | 116 | 6 | 6c7d03393a60dab954054e34ea842cc77412eb19 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.62e-06 | 175 | 116 | 6 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.62e-06 | 175 | 116 | 6 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.06e-06 | 177 | 116 | 6 | 191c14e0ef162536028b841f3759aaddef59b49d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-06 | 180 | 116 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-06 | 180 | 116 | 6 | de87503d9caac3ebc80ab8090c1a9ee5a925b2a0 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-06 | 180 | 116 | 6 | 978728c89497d26287f73974fb738ad9fde61415 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 182 | 116 | 6 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.54e-06 | 183 | 116 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 185 | 116 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 185 | 116 | 6 | ea3ff0bd3f312bd2e93227ecf6ed577366aab3e0 | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.66e-06 | 187 | 116 | 6 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.66e-06 | 187 | 116 | 6 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.66e-06 | 187 | 116 | 6 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.03e-05 | 189 | 116 | 6 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 190 | 116 | 6 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 190 | 116 | 6 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 190 | 116 | 6 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.09e-05 | 191 | 116 | 6 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.19e-05 | 194 | 116 | 6 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 197 | 116 | 6 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-05 | 198 | 116 | 6 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 198 | 116 | 6 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | de55100e98d3e9b8a74e37aebcd3afa2b0996527 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 200 | 116 | 6 | 69295705fc614c2687f2b6c8e6aa0c6717841008 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.99e-05 | 126 | 116 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | facs-Skin-Anagen-24m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 138 | 116 | 5 | e8faf333553273b68a10b01470bb43a0383d6212 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 4.44e-05 | 149 | 116 | 5 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.89e-05 | 152 | 116 | 5 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.87e-05 | 158 | 116 | 5 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-05 | 166 | 116 | 5 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.63e-05 | 167 | 116 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.63e-05 | 167 | 116 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 169 | 116 | 5 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 169 | 116 | 5 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 170 | 116 | 5 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.53e-05 | 171 | 116 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-05 | 171 | 116 | 5 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-05 | 171 | 116 | 5 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 8.53e-05 | 171 | 116 | 5 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.77e-05 | 172 | 116 | 5 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 172 | 116 | 5 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 172 | 116 | 5 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 8.77e-05 | 172 | 116 | 5 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 173 | 116 | 5 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 9.01e-05 | 173 | 116 | 5 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-05 | 174 | 116 | 5 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-05 | 174 | 116 | 5 | 096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.26e-05 | 174 | 116 | 5 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 176 | 116 | 5 | 096cbcefd9dcbaee660568998ba210253b58501e | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 176 | 116 | 5 | 359a57aea89d8e6776eaefb0c3553a0dbcad5e58 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 176 | 116 | 5 | 90198fb79e8b08e9e7df538cbc05ad7141e78517 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 177 | 116 | 5 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 177 | 116 | 5 | b5c20c1247f11ebc97e9cb47482564cd74e36ca6 | |
| ToppCell | wk_08-11-Epithelial-PNS-Late_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 178 | 116 | 5 | a7301c0bba03d10feacc02e3f929d9a9235fd25b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 179 | 116 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 179 | 116 | 5 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 180 | 116 | 5 | 03e3067ee313e8c40b702b9bc9981f9859d045a2 | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.09e-04 | 180 | 116 | 5 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 180 | 116 | 5 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 116 | 5 | e8a68214930a6d15c47207656601b2209e283aae | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 116 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 1.11e-04 | 181 | 116 | 5 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 181 | 116 | 5 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.70e-07 | 194 | 111 | 9 | 4246_DN | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 7.78e-07 | 104 | 111 | 7 | ctd:C000595015 | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.02e-06 | 194 | 111 | 8 | 4335_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.02e-06 | 194 | 111 | 8 | 3384_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 5.21e-06 | 195 | 111 | 8 | 4495_DN | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 2541_UP | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 3937_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A | 5.83e-06 | 198 | 111 | 8 | 4661_DN | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.87e-05 | 168 | 111 | 7 | 6087_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.35e-05 | 174 | 111 | 7 | 6048_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.41e-05 | 192 | 111 | 7 | 1286_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 4.55e-05 | 193 | 111 | 7 | 5914_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.55e-05 | 193 | 111 | 7 | 7147_UP | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.55e-05 | 193 | 111 | 7 | 7008_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 3674_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 1179_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 4242_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 4291_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 6063_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 6039_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 5618_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 6739_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 2122_DN | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 3374_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HG-U133A | 5.19e-05 | 197 | 111 | 7 | 1933_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; HL60; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 2909_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 5201_DN | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 7021_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 3456_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 5869_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 2472_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 7035_UP | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 2817_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 4197_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 7433_DN | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; HL60; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 2359_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 5295_DN | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 6634_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A | 5.53e-05 | 199 | 111 | 7 | 365_DN | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 7308_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 6265_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A | 5.53e-05 | 199 | 111 | 7 | 1945_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 7219_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.71e-05 | 200 | 111 | 7 | 6032_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.71e-04 | 167 | 111 | 6 | 6047_UP | |
| Drug | rosiglitazone; Up 200; 10uM; PC3; HT_HG-U133A | 1.76e-04 | 168 | 111 | 6 | 1233_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.13e-04 | 174 | 111 | 6 | 1302_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; PC3; HT_HG-U133A | 2.72e-04 | 182 | 111 | 6 | 5941_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.88e-04 | 184 | 111 | 6 | 2321_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.97e-04 | 185 | 111 | 6 | 3536_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 3.05e-04 | 186 | 111 | 6 | 4271_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.23e-04 | 188 | 111 | 6 | 986_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.42e-04 | 190 | 111 | 6 | 4340_DN | |
| Drug | ATN-2 | 3.49e-04 | 6 | 111 | 2 | CID003081684 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 3.62e-04 | 192 | 111 | 6 | 2081_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 3.62e-04 | 192 | 111 | 6 | 2722_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.72e-04 | 193 | 111 | 6 | 4146_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.72e-04 | 193 | 111 | 6 | 4286_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; HL60; HG-U133A | 3.82e-04 | 194 | 111 | 6 | 1585_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 3.82e-04 | 194 | 111 | 6 | 1239_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 3.82e-04 | 194 | 111 | 6 | 6417_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.82e-04 | 194 | 111 | 6 | 3173_UP | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.82e-04 | 194 | 111 | 6 | 4249_DN | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.82e-04 | 194 | 111 | 6 | 3716_UP | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 3.93e-04 | 195 | 111 | 6 | 333_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 5520_DN | |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 2813_DN | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 6052_UP | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 5631_DN | |
| Drug | (-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.93e-04 | 195 | 111 | 6 | 874_UP | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 5245_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA | 3.93e-04 | 195 | 111 | 6 | 1078_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; HL60; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 1859_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 4201_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.93e-04 | 195 | 111 | 6 | 5283_UP | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 4628_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 4594_DN | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 3452_DN | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 6007_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 7015_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 2978_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 3233_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 1326_UP | |
| Drug | prednisolone; Down 200; 1uM; MCF7; HG-U133A | 4.04e-04 | 196 | 111 | 6 | 265_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 1301_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 4238_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 4591_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 4494_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.04e-04 | 196 | 111 | 6 | 6014_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 4183_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 5939_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 7521_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 7401_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 2545_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 3930_DN | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 2148_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 2328_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 3473_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 4501_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | 4.15e-04 | 197 | 111 | 6 | 4673_DN | |
| Disease | brain measurement, neuroimaging measurement | ATXN2L PRR23A RIN3 GLIS3 SSBP3 MBD6 TFAP4 COL18A1 MAST4 KCNA5 ATXN7 ROBO1 | 9.49e-07 | 550 | 109 | 12 | EFO_0004346, EFO_0004464 |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | RIN3 MAP1A PRSS55 ZMIZ1 SSBP3 TFAP4 RSBN1 AAAS TNFSF11 ATF7IP BRD4 NOTCH1 EPHA8 | 9.67e-05 | 1015 | 109 | 13 | EFO_0004533 |
| Disease | cortical surface area measurement | ALX3 ATXN2L PRR23A RIN3 PRSS55 GLIS3 PARD3B CHD7 SSBP3 MBD6 TFAP4 MAST4 KCNA5 ROBO1 RERE | 1.28e-04 | 1345 | 109 | 15 | EFO_0010736 |
| Disease | neuroimaging measurement | ATXN2L PRR23A RBM26 GLIS3 CHD7 SSBP3 MBD6 TFAP4 COL18A1 MAST4 KCNA5 ROBO1 RERE | 1.61e-04 | 1069 | 109 | 13 | EFO_0004346 |
| Disease | Squamous cell carcinoma of lung | 2.25e-04 | 32 | 109 | 3 | C0149782 | |
| Disease | cortical thickness | PRR23A RIN3 GLIS3 CHD7 SSBP3 MBD6 TFAP4 COL18A1 TNFSF11 MAST4 KCNA5 ROBO1 RERE | 2.39e-04 | 1113 | 109 | 13 | EFO_0004840 |
| Disease | panhypopituitarism (is_implicated_in) | 2.81e-04 | 7 | 109 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | Angle Closure Glaucoma | 2.81e-04 | 7 | 109 | 2 | C0017605 | |
| Disease | testosterone measurement | ATXN2L CASC3 MAP1A CECR2 GLIS3 CCDC85C CHD7 IRX1 ZMIZ1 KDM6B KIAA0753 ZIC5 SKOR2 | 8.58e-04 | 1275 | 109 | 13 | EFO_0004908 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.00e-03 | 53 | 109 | 3 | C4707243 | |
| Disease | eosinophil count | RIN3 TCF7 CARMIL2 SIPA1L3 EFEMP2 CHD7 KDM6B SPATC1 FNDC1 TNFSF11 ATF7IP TLE3 RERE NOTCH1 | 1.17e-03 | 1488 | 109 | 14 | EFO_0004842 |
| Disease | Intellectual Disability | 1.38e-03 | 447 | 109 | 7 | C3714756 | |
| Disease | Cardiovascular Abnormalities | 1.57e-03 | 16 | 109 | 2 | C0243050 | |
| Disease | Feeding difficulties | 1.99e-03 | 18 | 109 | 2 | C0232466 | |
| Disease | vital capacity | ATXN2L RIN3 FN1 GLIS3 ID4 CHD7 IRX1 ZMIZ1 TRIM24 ZBTB24 BRD4 RIPOR1 | 2.06e-03 | 1236 | 109 | 12 | EFO_0004312 |
| Disease | Malignant neoplasm of breast | 2.10e-03 | 1074 | 109 | 11 | C0006142 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.15e-03 | 69 | 109 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.22e-03 | 19 | 109 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 2.24e-03 | 70 | 109 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | PR interval | 2.46e-03 | 495 | 109 | 7 | EFO_0004462 | |
| Disease | coagulation factor V measurement | 2.46e-03 | 20 | 109 | 2 | EFO_0008087 | |
| Disease | free androgen index | 2.70e-03 | 374 | 109 | 6 | EFO_0007005 | |
| Disease | bone density, lean body mass | 2.71e-03 | 21 | 109 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | tonsillectomy risk measurement | 2.84e-03 | 260 | 109 | 5 | EFO_0007924 | |
| Disease | Glioblastoma | 3.16e-03 | 79 | 109 | 3 | C0017636 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.25e-03 | 23 | 109 | 2 | C1708353 | |
| Disease | blood zinc measurement | 3.25e-03 | 23 | 109 | 2 | EFO_0007584 | |
| Disease | congenital heart disease (is_implicated_in) | 3.54e-03 | 24 | 109 | 2 | DOID:1682 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHPSPAKHGPVPSFP | 226 | Q5U5X8 | |
| LPGPPPVLPHSPHSH | 531 | Q9NRG9 | |
| LPPVAHPPHAPSPGQ | 411 | Q13363 | |
| PPHLPQPPEHSTPPH | 836 | O60885 | |
| PGPQGTPAAAPHLHP | 26 | O95076 | |
| HHRPPPGGPQVPPAL | 1031 | Q6F5E8 | |
| PATSQHPPPPPGHRS | 276 | P06729 | |
| HPPPPPGHRSQAPSH | 281 | P06729 | |
| PGHRSQAPSHRPPPP | 286 | P06729 | |
| PYPPGPAHLPPPHSQ | 541 | P54259 | |
| LPPLHAPTFPPHPVV | 201 | Q6P575 | |
| PTHAVPPHPPPGLGL | 526 | O75909 | |
| GPPAPGKPPHISSHP | 876 | Q9Y4F5 | |
| PHPQPSHQPPGAMGI | 431 | Q9P2D1 | |
| PPQPATLHHASPGPP | 266 | O60479 | |
| PYHPHQPAHPRLPGP | 921 | Q9BXF3 | |
| PVAALPPHHPGATQP | 1386 | Q9BXF3 | |
| SPPHPAPAPQHPAAS | 576 | Q9Y463 | |
| GITAAPPPHPGAPHP | 971 | Q8WWM7 | |
| VVTTGIHHQPPPAPP | 406 | Q5T8P6 | |
| HLAVPPPGAIPPALH | 276 | Q8N684 | |
| PHPHPLRPPGLGVNE | 91 | Q6ZSK4 | |
| TPPPQQHPPGPGPHL | 326 | Q86TB9 | |
| QHYPPPPAPQHKGPF | 1141 | Q8TEW8 | |
| QPAPALPSPHPSPLH | 201 | Q5HY92 | |
| PLPPSNNLPAHPGPA | 271 | Q96DN6 | |
| PPPPPQPHLGVSSAA | 2411 | P46531 | |
| HPPPSGLPPCPRLGH | 116 | Q9Y5Z7 | |
| HSHGPPLPQGPPPLL | 306 | P04196 | |
| THHPRPGHDPPPLPQ | 2551 | P78559 | |
| PQAHAHPHPSPPPSG | 66 | P13378 | |
| PDPEAGHPPQPPHSP | 26 | Q92952 | |
| GHPPQPPHSPGLQVV | 31 | Q92952 | |
| TAHPPGHRLVPAAPP | 321 | O15054 | |
| HHVPPPLLPPGPHKA | 221 | A6NKD9 | |
| PGHYDLPPVRHPPSP | 1016 | Q5VY43 | |
| PRLPEPQPYPGAPHH | 1541 | P39060 | |
| SPLHPGADATHPPPP | 36 | Q5QP82 | |
| PPSHPASQPPLPASH | 396 | O15117 | |
| KHTPQHPVPPSGAPP | 276 | Q9UPM6 | |
| PPPQASLHHLQPPGA | 661 | Q71SY5 | |
| PPAAAPGHPLAPGPH | 71 | P18627 | |
| PGHPLAPGPHPAAPS | 76 | P18627 | |
| RQPPPPAPPHHPAGT | 116 | P47928 | |
| PAPPHHPAGTCPAAP | 121 | P47928 | |
| PPVHESPHPPLPATE | 471 | O15265 | |
| AAAPGHSAVPPPPPQ | 106 | Q8WY54 | |
| LQGPPSQTPLPGPHH | 466 | Q75N03 | |
| GQKLPIAHTPPPPPA | 1181 | Q96JP2 | |
| LLRHPPAPHQPPAPA | 281 | P22460 | |
| PHPGLHPHQTPAPLP | 581 | O15234 | |
| PPPAPAAPCGPHGLH | 51 | Q5SW24 | |
| LGSPTPPPPPPHQRH | 1821 | Q14185 | |
| APGPLAPLAPSHPHP | 411 | Q9BQW3 | |
| SPPHPHLLPTTPAAP | 271 | Q96PV7 | |
| PQPHPQPPPYGHCVT | 296 | P02751 | |
| PHPPHRPHGLPQHPQ | 381 | Q9UPW0 | |
| AHPPAHPPPSAAAPA | 21 | Q8WYQ3 | |
| PPPPVATSQHHPGPQ | 1006 | Q4ZHG4 | |
| ALHPGCFAPLHPPPP | 151 | P17676 | |
| NGQAPPPVFLPLHHP | 586 | P29322 | |
| GAVPPPHPVSHPSPG | 571 | Q8NEA6 | |
| VPPPPRAPQAGAHTP | 696 | O15063 | |
| PHQHSGPAPPAAVPP | 71 | Q9GZT9 | |
| PPQVHTEPPRPVHPA | 1126 | Q6VMQ6 | |
| PVHLPRPGHPGPSEP | 2301 | O15021 | |
| PAVPVHPVPPPHALA | 81 | Q04743 | |
| HPVPPPHALAAHPLP | 86 | Q04743 | |
| LHGEGPPPPVPPAQH | 91 | O95967 | |
| GDSPHLPSPHPTRPP | 786 | Q9NZM4 | |
| VPPAAPHHGQPQPPH | 61 | Q9UJU5 | |
| LPTSPPVPAPHVTPH | 311 | Q8TB24 | |
| PVPAPHVTPHAPGPP | 316 | Q8TB24 | |
| GLLHNGFHPPPVQPP | 166 | Q8TE04 | |
| HPGPLPPTNAAPTVP | 121 | Q5VWQ0 | |
| PHHPPHLPPPGQFVP | 281 | Q9H0F5 | |
| GSQPSPHAQPPPHNP | 126 | Q9BWW4 | |
| QVPRPSPGHHHPPAV | 51 | Q6ZWK4 | |
| PSPRVGSPGPHAHPP | 236 | A6NEV1 | |
| GSPGPHAHPPLPKRP | 241 | A6NEV1 | |
| PALFPHPPHTPDPLA | 201 | Q5VVP1 | |
| APHAAPHGPHLPAPP | 396 | P78414 | |
| PPLHSLHPAPGPIPG | 421 | O15353 | |
| EPVHPPGKIPHQGPP | 236 | Q569H4 | |
| PALFPHPPHTPDPLA | 201 | Q8IWB4 | |
| QHPHPPVGPGATPAA | 1591 | O60292 | |
| PPASHPPTGLHQVAP | 1016 | Q9P2R6 | |
| PHLRPPPPSHVPAGG | 101 | Q6P9B9 | |
| PPTHDPGLQPHPRIG | 191 | Q2KHM9 | |
| PPPPPPAHALQHYLS | 301 | Q9ULL5 | |
| PPPAPGVHPPAPVVH | 281 | Q15428 | |
| GVHPPAPVVHPPASG | 286 | Q15428 | |
| APVVHPPASGVHPPA | 291 | Q15428 | |
| PPASGVHPPAPGVHP | 296 | Q15428 | |
| VHPPAPGVHPPAPGV | 301 | Q15428 | |
| VHPPAPGVHPPAPGV | 336 | Q15428 | |
| GVHPPAPGVHPPPSA | 356 | Q15428 | |
| APGVHPPPSAGVHPQ | 361 | Q15428 | |
| PPPSAGVHPQAPGVH | 366 | Q15428 | |
| PAAPAVHPQAPGVHP | 381 | Q15428 | |
| VHPQAPGVHPPAPGM | 386 | Q15428 | |
| PGVHPPAPGMHPQAP | 391 | Q15428 | |
| PPGVHPSAPGVHPQP | 411 | Q15428 | |
| PSAPGVHPQPPGVHP | 416 | Q15428 | |
| VHPQPPGVHPSNPGV | 421 | Q15428 | |
| PGVHPSNPGVHPPTP | 426 | Q15428 | |
| PLHPLPPDGAIHCPP | 786 | O94875 | |
| IPHPHVYQPPPLGHP | 586 | O94993 | |
| DSHPPDLGPPHIPVP | 946 | Q15047 | |
| PSPRYEAPPPTPHHH | 1381 | Q9Y566 | |
| PPTKPPSFNLHPAPH | 76 | Q99966 | |
| RPPPLPAHTPAHTPE | 66 | P28329 | |
| PALFPHPPHTPDPLA | 201 | Q5VYP0 | |
| PHPGPIPKHLAPSPA | 286 | Q32MQ0 | |
| NHSPKPNGPVLPPHP | 521 | O15164 | |
| PALFPHPPHTPDPLA | 201 | Q5TZJ5 | |
| PALFPHPPHTPDPLA | 201 | Q5VU36 | |
| LPVPHCPPHNAHSPP | 376 | Q76KD6 | |
| HGHHPQSLQPPPHPP | 251 | Q6H3X3 | |
| LPPPPAHPPPHSNSE | 1186 | Q9Y6N7 | |
| DRGSRVPHPHPHPPP | 931 | Q14151 | |
| PTLHPAPAGHLPCPP | 196 | O75360 | |
| GHPAAIPHPAIVPPS | 226 | P36402 | |
| PPPGLPSLHSLGHPP | 236 | Q9NPC8 | |
| PPPPPPLAQHPHHRG | 701 | Q2VWA4 | |
| ATHGPPVQLPPHPSG | 136 | Q04726 | |
| QRPPKPGGHHRHPPP | 71 | Q16378 | |
| PGGHHRHPPPPPFQN | 76 | Q16378 | |
| RGAHRPQPPHPPSPV | 36 | Q6UWB4 | |
| HEGPLHAPPPPAPHQ | 26 | O14788 | |
| HAPPPPAPHQPPAAS | 31 | O14788 | |
| GPAPQHPAAPASPPR | 201 | F5GYI3 | |
| EPGPPPPTHHVPQPT | 676 | O43167 | |
| PPTHHVPQPTPLGQE | 681 | O43167 | |
| PSPPTHPAPTHGEHP | 481 | Q6ZS17 | |
| HPAPTHGEHPSPVPP | 486 | Q6ZS17 | |
| PPAPTHHPTVIVPAP | 226 | Q01664 | |
| IVPAPPPPPSHHINV | 236 | Q01664 | |
| PPPPSHHINVVTMGP | 241 | Q01664 | |
| SPHPHNAFVPPPPTL | 1246 | Q702N8 | |
| NPVHSPGPAGPVSHP | 331 | A6NGD5 | |
| QSGPPLHHSGAPPPP | 971 | Q9ULJ6 | |
| LHHSGAPPPPPSQPP | 976 | Q9ULJ6 | |
| PGIPGHHAAIKPAPP | 406 | Q15061 | |
| GPGPHLQHHAPPPAP | 346 | Q96T25 | |
| VPQPGLPPPHGINSH | 2551 | O14686 | |
| PPHKGAPNPAVVTPP | 1281 | E9PAV3 |